Skip to main content
The NCI Community Hub will be retiring in spring 2024. Stay tuned for information in the coming month.
  • Discoverability Visible
  • Join Policy Restricted
  • Created 09 Sep 2014
Search Posts
91 Data Submission 0 Discussions 0 Posts
93 In Vivo Characterizations--Prioritizations for Phase II caNanoLab Enhancements As part of the Phase II caNanoLab enhancements, we would like to add metadata for in vivo characterizations to the relevant pull-down menus of the web-based data submission forms. It would be very helpful if you could help us prioritize which in vivo characterizations should be added to the submission forms (i.e., toxicology, pharmacokinetics (PK), efficacy, animal/treatment, imaging), as well as the concepts (measurements and assays) that are most applicable to your research and the biomedical nanotechnology field in general. A file containing concepts associated with each of these characterizations can be found at for your review and feedback in this discussion. 1 Discussions 1 Posts
85 Login Process Default category for all discussions in this forum. 0 Discussions 0 Posts
86 My Workspace Feature 0 Discussions 0 Posts
90 Protocol Search and Retrieval 0 Discussions 0 Posts
89 Publication Search and Retrieval 0 Discussions 0 Posts
88 Sample Information Search and Retrieval 0 Discussions 0 Posts